SJIM
OGEN icon

St. Johns Investment Management’s Oragenics OGEN Stock Holding History

St. Johns Investment Management’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12K Buy
1,924
+1,724
+862% +$1.05K ﹤0.01% 189
2026
Q1 		$112 Buy
+200
New +$158 ﹤0.01% 191

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
2L
25 LLC St. Louis, Missouri $365M AUM 18.53% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
ASCM
Adkins Seale Capital Management Shreveport, Louisiana $112M AUM

St. Johns Investment Management's OGEN Position: Q2 2026 in Review

St. Johns Investment Management increased its Oragenics (OGEN) stake by 862% in Q2 2026, buying an estimated $1.05K and bringing the position to 1,924 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #189.

St. Johns Investment Management first reported a position in OGEN in Q1 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold OGEN as of Q2 2026.

  • St. Johns Investment Management held 1,924 shares of Oragenics worth $1.12K as of Q2 2026.
  • St. Johns Investment Management bought 1,724 Oragenics shares in Q2 2026, an estimated $1.05K.
  • Oragenics made up ﹤0.01% of St. Johns Investment Management's portfolio in Q2 2026, its #189 holding.
  • St. Johns Investment Management first reported a position in Oragenics in Q1 2026 and has held it in 2 quarters since.
  • 17 funds tracked by Wall St. Rank held Oragenics as of Q2 2026.

Based on St. Johns Investment Management's 13F filing for Q2 2026, filed 4 Aug 2026.